EyePoint
Showing 1 - 18 of 18
Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)
Recruiting
- Wet Age-related Macular Degeneration
- Eyp-1901
- Aflibercept 2Mg/0.05Ml Inj,Oph
-
Melbourne, Florida
- +4 more
Aug 18, 2022
Cataract Trial in Palo Alto, Charleston (Dexamethasone, Prednisolone Acetate Ophthalmic)
Recruiting
- Cataract
- Dexamethasone
- Prednisolone Acetate Ophthalmic
-
Palo Alto, California
- +1 more
Jan 3, 2022
Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)
Active, not recruiting
- Uveitis
- +2 more
- Sham Injector
- FAI Insert
-
Waltham, MassachusettsEyePoint Study Site
Dec 20, 2022
Cataract Trial in Largo (Dexycu, Standard of Care post operative eye drops (steroid, antibiotic, NSAID))
Recruiting
- Cataract
- Dexycu
- Standard of Care post operative eye drops (steroid, antibiotic, NSAID)
-
Largo, FloridaThe Eye Institute of West Florida
Mar 1, 2021
Diabetic Macular Edema Trial (EYP-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)
Not yet recruiting
- Diabetic Macular Edema
- EYP-1901
- Aflibercept 2Mg/0.05Ml Inj,Oph
- (no location specified)
Oct 19, 2023
Nonproliferative Diabetic Retinopathy Trial (EYP-1901, Sham IVT)
Not yet recruiting
- Nonproliferative Diabetic Retinopathy
- EYP-1901
- Sham IVT
- (no location specified)
Aug 3, 2022
Uveitis, Posterior Trial in United States (Fluocinolone Acetonide Intravitreal Implant 0.18 mg)
Recruiting
- Uveitis, Posterior
- Fluocinolone Acetonide Intravitreal Implant 0.18 mg
-
Phoenix, Arizona
- +16 more
Aug 18, 2022
DEXYCU 9% Retrospective Study 001
Completed
- Cataract
- DEXYCU (dexamethasone intraocular suspension) 9%.
-
Dothan, Alabama
- +21 more
May 24, 2021
Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)
Not yet recruiting
- Uveitis
- +3 more
- Yutiq 0.18 MG Drug Implant
- Sham Injection
-
Plano, TexasTexas Retina Associates
Aug 3, 2022
Imaging of Uveitis Patients Receiving Injectable Fluocinolone
Recruiting
- Uveitis
- Fluocinolone Acetonide
-
Cleveland, OhioCole Eye Institute Cleveland Clinic Foundation
Apr 27, 2022
Non-Infectious Uveitis Trial in Worldwide (FAI insert, Sham injection)
Completed
- Non-Infectious Uveitis
- FAI insert
- Sham injection
-
Beverly Hills, California
- +33 more
Mar 5, 2021
Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)
Completed
- Posterior Uveitis
- +2 more
- Sham Injection
- FAI Insert
-
Hyderabad, Andhra Pradesh, India
- +14 more
Jul 10, 2020
Cataract Trial in Laguna Hills, Garden City (Dexycu intracameral dexamethasone, Prednisolone Acetate)
Completed
- Cataract
- Dexycu intracameral dexamethasone
- Prednisolone Acetate
-
Laguna Hills, California
- +1 more
Dec 9, 2020
Non-Infectious Uveitis Trial in United States (FAI Insert administered using the Mk II inserter, FAI Insert administered using
Completed
- Non-Infectious Uveitis
- FAI Insert administered using the Mk II inserter
- FAI Insert administered using the Mk I inserter
-
Colorado Springs, Colorado
- +5 more
Apr 22, 2020
Inflammatory Reaction Due to Ocular Lens Prosthesis Trial in Los Altos (IBI-10090)
Terminated
- Inflammatory Reaction Due to Ocular Lens Prosthesis
-
Los Altos, CaliforniaAltos Eye Physicians
Nov 6, 2018